137 related articles for article (PubMed ID: 20842609)
1. [Metastatic gastric cancer: does second-line chemotherapy make sense?].
Breithaupt K; Thuss-Patience PC
Dtsch Med Wochenschr; 2010 Sep; 135(38):1872-6. PubMed ID: 20842609
[No Abstract] [Full Text] [Related]
2. Docetaxel/cisplatin followed by FOLFIRI versus the reverse sequence in metastatic gastric cancer.
Kim JA; Lee J; Han B; Park SH; Park JO; Park YS; Lim HY; Kang WK
Cancer Chemother Pharmacol; 2011 Jul; 68(1):177-84. PubMed ID: 20878159
[TBL] [Abstract][Full Text] [Related]
3. [Patient with stomach cancer with metastases. What is the value of chemotherapy?].
Wilke H; Stahl M; Vanhoefer U
MMW Fortschr Med; 2003 Nov; 145(48):39-42. PubMed ID: 14724998
[TBL] [Abstract][Full Text] [Related]
4. [Palliative anti-cancer chemotherapy is safely executable in a hemodialytic patient with unresectable advanced gastric cancer].
Miura T; Hosojima Y; Nakamura J; Yamada S; Nakazawa Y; Ozeki Y; Miura T; Yanagi M; Yamazaki H; Takahashi T
Gan To Kagaku Ryoho; 2011 Mar; 38(3):453-6. PubMed ID: 21403453
[TBL] [Abstract][Full Text] [Related]
5. [CPT-11 combined chemotherapy for metastatic gastric cancer].
Narahara H; Sugimoto N; Iishi H; Tatsuta M
Gan To Kagaku Ryoho; 2004 Nov; 31(12):1973-7. PubMed ID: 15570923
[TBL] [Abstract][Full Text] [Related]
6. Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis.
Kim HS; Kim HJ; Kim SY; Kim TY; Lee KW; Baek SK; Kim TY; Ryu MH; Nam BH; Zang DY
Ann Oncol; 2013 Nov; 24(11):2850-4. PubMed ID: 23942775
[TBL] [Abstract][Full Text] [Related]
7. [Standard chemotherapy for gastric cancer].
Sasaki T; Kobayashi T; Okamoto R; Omuro Y
Nihon Rinsho; 2001 Apr; 59 Suppl 4():350-7. PubMed ID: 11424405
[No Abstract] [Full Text] [Related]
8. Is there a role for second-line chemotherapy in advanced gastric cancer?
Wesolowski R; Lee C; Kim R
Lancet Oncol; 2009 Sep; 10(9):903-12. PubMed ID: 19717092
[TBL] [Abstract][Full Text] [Related]
9. [New chemotherapeutic options in advanced gastric cancer].
Höhler T; Möhler M
Onkologie; 2003 Dec; 26 Suppl 7():54-9. PubMed ID: 14716144
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer.
Quintero-Aldana G; Jorge M; Grande C; Salgado M; Gallardo E; Varela S; López C; Villanueva MJ; Fernández A; Alvarez E; González P; Castellanos J; Casal J; López R; Campos Balea B
Cancer Chemother Pharmacol; 2015 Oct; 76(4):731-7. PubMed ID: 26242221
[TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced gastric cancer: where we are in 2003.
Ducreux M; Boige V
Onkologie; 2003 Jun; 26(3):214-5. PubMed ID: 12845204
[No Abstract] [Full Text] [Related]
12. Palliative chemotherapy for advanced gastric cancer.
Wöhrer SS; Raderer M; Hejna M
Ann Oncol; 2004 Nov; 15(11):1585-95. PubMed ID: 15520058
[TBL] [Abstract][Full Text] [Related]
13. Developments in the treatment of gastric cancer in Europe.
Köhne CH; Wils JA; Wilke HJ
Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):22-5. PubMed ID: 11200144
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy for gastric cancer].
Baba H; Kakeji Y; Oki E; Tokunaga E; Ushiro S; Watanabe M; Maehara Y
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1881-8. PubMed ID: 14650954
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of irinotecan and docetaxel combination chemotherapy for patients with previously treated metastatic or recurrent advanced gastric cancer.
Sym SJ; Chang HM; Kang HJ; Lee SS; Ryu MH; Lee JL; Kim TW; Yook JH; Oh ST; Kim BS; Kang YK
Cancer Chemother Pharmacol; 2008 Dec; 63(1):1-8. PubMed ID: 18288477
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy of irinotecan (CPT-11) combined with cisplatin in patients with advanced gastric cancer].
Sato A; Shimada K; Nakamachi M; Wada M; Koda T; Matsukawa M
Nihon Rinsho; 2001 Apr; 59 Suppl 4():375-80. PubMed ID: 11424409
[No Abstract] [Full Text] [Related]
17. Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer.
Park KW; Ahn JS; Park YS; Lee J; Kang JH; Park JO; Lim HY; Im YH; Kang WK; Park K; Lee SI
Cancer Chemother Pharmacol; 2007 Jan; 59(1):17-21. PubMed ID: 16721549
[TBL] [Abstract][Full Text] [Related]
18. [Basic strategies on first- and second-line chemotherapy for advanced gastric cancers].
Yoshida S
Nihon Shokakibyo Gakkai Zasshi; 2007 Feb; 104(2):171-6. PubMed ID: 17283410
[No Abstract] [Full Text] [Related]
19. Irinotecan Monotherapy Versus Irinotecan-Based Combination as Second-Line Chemotherapy in Advanced Gastric Cancer: A Meta-Analysis.
Cho YH; Yoon SY; Kim SN
Cancer Res Treat; 2017 Jan; 49(1):255-262. PubMed ID: 27188198
[TBL] [Abstract][Full Text] [Related]
20. Advanced gastric cancer: Current treatment landscape and future perspectives.
Digklia A; Wagner AD
World J Gastroenterol; 2016 Feb; 22(8):2403-14. PubMed ID: 26937129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
